Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 7.75

(0.0%)

Total Liabilities Summary of Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd.'s latest annual total liabilities in 2023 was 2.64 Billion CNY , up 16.66% from previous year.
Charmacy Pharmaceutical Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 2.67 Billion CNY , up 1.08% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported annual total liabilities of 2.27 Billion CNY in 2022, up 0.55% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported annual total liabilities of 2.25 Billion CNY in 2021, down -1.65% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported quarterly total liabilities of 2.64 Billion CNY for 2023 Q4, up 17.23% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported quarterly total liabilities of 2.26 Billion CNY for 2023 Q2, down -0.49% from previous quarter.

Annual Total Liabilities Chart of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual Total Liabilities of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2023	2.64 Billion CNY	16.66%
2022	2.27 Billion CNY	0.55%
2021	2.25 Billion CNY	-1.65%
2020	2.29 Billion CNY	13.69%
2019	2.02 Billion CNY	7.62%
2018	1.87 Billion CNY	-6.53%
2017	2 Billion CNY	20.35%
2016	1.66 Billion CNY	1.22%
2015	1.64 Billion CNY	27.97%
2014	1.28 Billion CNY	4.28%
2013	1.23 Billion CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	2.67 Billion CNY	1.08%
2023 Q4	2.64 Billion CNY	17.23%
2023 Q2	2.26 Billion CNY	-0.49%
2023 FY	2.64 Billion CNY	16.66%
2022 FY	2.27 Billion CNY	0.55%
2022 Q4	2.27 Billion CNY	7.06%
2022 Q2	2.12 Billion CNY	-6.08%
2021 FY	2.25 Billion CNY	-1.65%
2021 Q4	2.25 Billion CNY	0.54%
2021 Q2	2.24 Billion CNY	-2.18%
2020 Q2	1.9 Billion CNY	-5.83%
2020 FY	2.29 Billion CNY	13.69%
2020 Q4	2.29 Billion CNY	20.73%
2019 FY	2.02 Billion CNY	7.62%
2019 Q4	2.02 Billion CNY	7.12%
2019 Q2	1.88 Billion CNY	0.47%
2018 FY	1.87 Billion CNY	-6.53%
2018 Q4	1.87 Billion CNY	4.02%
2018 Q2	1.8 Billion CNY	-10.14%
2017 Q2	1.84 Billion CNY	10.34%
2017 FY	2 Billion CNY	20.35%
2017 Q4	2 Billion CNY	9.07%
2016 FY	1.66 Billion CNY	1.22%
2016 Q2	1.62 Billion CNY	-1.39%
2016 Q4	1.66 Billion CNY	2.65%
2015 Q2	1.47 Billion CNY	14.25%
2015 Q4	1.64 Billion CNY	12.0%
2015 FY	1.64 Billion CNY	27.97%
2014 FY	1.28 Billion CNY	4.28%
2014 Q4	1.28 Billion CNY	0.0%
2013 FY	1.23 Billion CNY	0.0%

Peer Total Liabilities Comparison of Charmacy Pharmaceutical Co., Ltd.

Name	Total Liabilities	Total Liabilities Difference
Wanjia Group Holdings Limited	41.9 Million HKD	-6223.317%
China Health Group Limited	132.56 Million HKD	-1898.936%
Tai United Holdings Limited	3.52 Billion HKD	24.797%